Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine

Whole-body MRI of neuroblastoma

(2009) Hyun Woo Goo   EUROPEAN JOURNAL OF RADIOLOGY

Comparison of Iodine-123 Metaiodobenzylguanidine (MIBG) Scan and [18F]Fluorodeoxyglucose Positron Emission Tomography to Evaluate Response After Iodine-131 MIBG Therapy for Relapsed Neuroblastoma

(2009) Denah R. Taggart et al.   JOURNAL OF CLINICAL ONCOLOGY

Bone Metastases in Patients with Neuroendocrine Tumor: 68Ga-DOTA-Tyr3-Octreotide PET in Comparison to CT and Bone Scintigraphy

(2009) D. Putzer et al.   JOURNAL OF NUCLEAR MEDICINE

Usefulness of 123I-MIBG Scintigraphy in the Evaluation of Patients with Known or Suspected Primary or Metastatic Pheochromocytoma or Paraganglioma: Results from a Prospective Multicenter Trial

(2009) G. A. Wiseman et al.   JOURNAL OF NUCLEAR MEDICINE

18F-FDOPA PET and PET/CT Accurately Localize Pheochromocytomas

(2009) F. Imani et al.   JOURNAL OF NUCLEAR MEDICINE

Added Value of SPECT/CT for Correlation of MIBG Scintigraphy and Diagnostic CT in Neuroblastoma and Pheochromocytoma

(2008) Katia Rozovsky et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Comparison of 6-18F-Fluorodopamine PET with 123I-Metaiodobenzylguanidine and 111In-Pentetreotide Scintigraphy in Localization of Nonmetastatic and Metastatic Pheochromocytoma

(2008) I. Ilias et al.   JOURNAL OF NUCLEAR MEDICINE

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological Examinations

(2008) Anders Sundin et al.   NEUROENDOCRINOLOGY